IL276598A - Antibodies to FMS-like receptor tyrosine kinase 3 ligand and their uses for the treatment of autoimmune and inflammatory diseases - Google Patents
Antibodies to FMS-like receptor tyrosine kinase 3 ligand and their uses for the treatment of autoimmune and inflammatory diseasesInfo
- Publication number
- IL276598A IL276598A IL276598A IL27659820A IL276598A IL 276598 A IL276598 A IL 276598A IL 276598 A IL276598 A IL 276598A IL 27659820 A IL27659820 A IL 27659820A IL 276598 A IL276598 A IL 276598A
- Authority
- IL
- Israel
- Prior art keywords
- flt3l
- fms
- antibodies
- tyrosine kinase
- inflammatory diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/104—Lupus erythematosus [SLE]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862630571P | 2018-02-14 | 2018-02-14 | |
| PCT/US2019/017877 WO2019160976A1 (en) | 2018-02-14 | 2019-02-13 | Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL276598A true IL276598A (en) | 2020-09-30 |
Family
ID=67619040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL276598A IL276598A (en) | 2018-02-14 | 2020-08-09 | Antibodies to FMS-like receptor tyrosine kinase 3 ligand and their uses for the treatment of autoimmune and inflammatory diseases |
Country Status (13)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3752195A4 (en) * | 2018-02-14 | 2021-11-17 | Viela Bio, Inc. | FELINE MCDONOUGH'S SARCOMA (FMS) -LIKE TYROSINKINASE-3 RECEPTOR LIGANDS (FLT3L) ANTIBODIES AND USES THEREOF IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| JPS5896026A (ja) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4609546A (en) | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| DE3587814T2 (de) | 1985-03-30 | 1994-11-10 | Marc Ballivet | Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren. |
| US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| DE3600905A1 (de) | 1986-01-15 | 1987-07-16 | Ant Nachrichtentech | Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen |
| JPS63502716A (ja) | 1986-03-07 | 1988-10-13 | マサチューセッツ・インステチュート・オブ・テクノロジー | 糖タンパク安定性の強化方法 |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP0478627A4 (en) | 1989-05-16 | 1992-08-19 | William D. Huse | Co-expression of heteromeric receptors |
| CA2016842A1 (en) | 1989-05-16 | 1990-11-16 | Richard A. Lerner | Method for tapping the immunological repertoire |
| CA2016841C (en) | 1989-05-16 | 1999-09-21 | William D. Huse | A method for producing polymers having a preselected activity |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| EP0544809B1 (en) | 1990-08-24 | 1998-12-16 | Ixsys, Inc. | Methods of synthesizing oligonucleotides with random codons |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| IE914504A1 (en) | 1990-12-20 | 1992-07-01 | Ixsys | Optimization of binding proteins |
| JP3540315B2 (ja) | 1991-09-23 | 2004-07-07 | メディカル リサーチ カウンシル | キメラ抗体の製造−組合せアプローチ |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| WO1993011794A1 (en) | 1991-12-13 | 1993-06-24 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| AU6132994A (en) | 1993-02-02 | 1994-08-29 | Scripps Research Institute, The | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| US7534867B1 (en) | 1993-05-19 | 2009-05-19 | Schering Corporation | Purified mammalian Flt3 ligands; agonists; antagonists |
| US7045128B2 (en) | 1993-05-24 | 2006-05-16 | Immunex Corporation | Antibodies against flt3-ligand |
| US6630143B1 (en) * | 1993-05-24 | 2003-10-07 | Immunex Corporation | Antibodies against flt3 ligand |
| US5554512A (en) * | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| US6828422B1 (en) | 1995-08-18 | 2004-12-07 | Morphosys Ag | Protein/(poly)peptide libraries |
| US6331431B1 (en) | 1995-11-28 | 2001-12-18 | Ixsys, Inc. | Vacuum device and method for isolating periplasmic fraction from cells |
| US5714352A (en) | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
| AU8691398A (en) | 1997-08-04 | 1999-02-22 | Ixsys, Incorporated | Methods for identifying ligand specific binding molecules |
| US6602994B1 (en) | 1999-02-10 | 2003-08-05 | Hercules Incorporated | Derivatized microfibrillar polysaccharide |
| ATE482275T1 (de) | 1999-07-02 | 2010-10-15 | Morphosys Ag | Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden |
| SK782002A3 (en) * | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| ATE316239T1 (de) * | 2000-06-28 | 2006-02-15 | Us Gov Sec Navy | Vorrichtung und verfahren zur pneumatischen probenahme für gassensoren |
| EP1355919B1 (en) | 2000-12-12 | 2010-11-24 | MedImmune, LLC | Molecules with extended half-lives, compositions and uses thereof |
| JP4394350B2 (ja) * | 2001-01-09 | 2010-01-06 | ベイラー リサーチ インスティテュート | 対象における自己免疫疾患の治療法及びinvitro診断アッセイ |
| US7538195B2 (en) | 2002-06-14 | 2009-05-26 | Immunogen Inc. | Anti-IGF-I receptor antibody |
| WO2004003144A2 (en) | 2002-07-01 | 2004-01-08 | Human Genome Sciences, Inc. | Antibodies that specifically bind to reg iv |
| DK1578446T3 (en) | 2002-11-07 | 2015-06-29 | Immunogen Inc | ANTI-CD33 ANTIBODIES AND PROCEDURES FOR TREATING ACUTE MYELOID LEUKEMIA BY USING IT |
| JP5704785B2 (ja) | 2004-07-19 | 2015-04-22 | ザ・ジョンズ・ホプキンス・ユニバーシティ | 免疫抑制のためのflt3阻害剤 |
| US20060142430A1 (en) | 2004-12-29 | 2006-06-29 | Harrington John C | Retention and drainage in the manufacture of paper |
| MX2010008578A (es) | 2008-02-08 | 2010-11-10 | Medimmune Llc | Anticuerpos anti-receptor 1 de interferon alfa con afinidad reducida al ligando fc. |
| WO2011048000A1 (de) | 2009-10-20 | 2011-04-28 | Basf Se | Verfahren zur herstellung von papier, pappe und karton mit hoher trockenfestigkeit |
| WO2011113041A2 (en) | 2010-03-12 | 2011-09-15 | The Johns Hopkins University | Neutralization of flt3 ligand as a leukemia therapy |
| US9415118B2 (en) | 2013-03-13 | 2016-08-16 | Novartis Ag | Antibody drug conjugates |
| CN107073070A (zh) * | 2014-08-15 | 2017-08-18 | 格纳西尼有限公司 | 治疗宫颈癌的方法 |
| EP3752195A4 (en) | 2018-02-14 | 2021-11-17 | Viela Bio, Inc. | FELINE MCDONOUGH'S SARCOMA (FMS) -LIKE TYROSINKINASE-3 RECEPTOR LIGANDS (FLT3L) ANTIBODIES AND USES THEREOF IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES |
-
2019
- 2019-02-13 EP EP19754925.6A patent/EP3752195A4/en active Pending
- 2019-02-13 US US16/969,774 patent/US11512127B2/en active Active
- 2019-02-13 BR BR112020016400-3A patent/BR112020016400A2/pt active Search and Examination
- 2019-02-13 KR KR1020257030589A patent/KR20250139415A/ko active Pending
- 2019-02-13 CN CN201980013516.0A patent/CN111989117B/zh active Active
- 2019-02-13 CA CA3091184A patent/CA3091184A1/en active Pending
- 2019-02-13 CN CN202510100026.1A patent/CN119971026A/zh active Pending
- 2019-02-13 WO PCT/US2019/017877 patent/WO2019160976A1/en not_active Ceased
- 2019-02-13 AU AU2019222705A patent/AU2019222705B2/en active Active
- 2019-02-13 JP JP2020543802A patent/JP7525397B2/ja active Active
- 2019-02-13 KR KR1020207026493A patent/KR102903323B1/ko active Active
- 2019-02-13 MX MX2020008479A patent/MX2020008479A/es unknown
- 2019-02-13 SG SG11202007702UA patent/SG11202007702UA/en unknown
-
2020
- 2020-08-09 IL IL276598A patent/IL276598A/en unknown
- 2020-08-12 CL CL2020002088A patent/CL2020002088A1/es unknown
- 2020-08-13 MX MX2024015370A patent/MX2024015370A/es unknown
-
2022
- 2022-07-21 US US17/814,075 patent/US12209123B2/en active Active
-
2023
- 2023-07-21 JP JP2023118763A patent/JP7756686B2/ja active Active
-
2024
- 2024-11-07 JP JP2024195419A patent/JP2025013590A/ja active Pending
- 2024-12-18 US US18/985,999 patent/US20250122276A1/en active Pending
-
2026
- 2026-01-07 AU AU2026200083A patent/AU2026200083A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN119971026A (zh) | 2025-05-13 |
| JP7525397B2 (ja) | 2024-07-30 |
| US11512127B2 (en) | 2022-11-29 |
| JP2025013590A (ja) | 2025-01-24 |
| JP2023139148A (ja) | 2023-10-03 |
| AU2019222705B2 (en) | 2025-10-09 |
| US20250122276A1 (en) | 2025-04-17 |
| MX2020008479A (es) | 2020-11-24 |
| JP7756686B2 (ja) | 2025-10-20 |
| RU2020129978A (ru) | 2022-03-14 |
| US12209123B2 (en) | 2025-01-28 |
| KR20200135331A (ko) | 2020-12-02 |
| SG11202007702UA (en) | 2020-09-29 |
| BR112020016400A2 (pt) | 2020-12-15 |
| AU2026200083A1 (en) | 2026-02-05 |
| WO2019160976A1 (en) | 2019-08-22 |
| MX2024015370A (es) | 2025-02-10 |
| EP3752195A1 (en) | 2020-12-23 |
| KR102903323B9 (ko) | 2026-02-13 |
| US20210002360A1 (en) | 2021-01-07 |
| US20230056815A1 (en) | 2023-02-23 |
| AU2019222705A1 (en) | 2020-10-01 |
| JP2021513357A (ja) | 2021-05-27 |
| EP3752195A4 (en) | 2021-11-17 |
| CN111989117B (zh) | 2025-02-18 |
| CL2020002088A1 (es) | 2020-12-11 |
| KR102903323B1 (ko) | 2025-12-23 |
| CN111989117A (zh) | 2020-11-24 |
| CA3091184A1 (en) | 2019-08-22 |
| KR20250139415A (ko) | 2025-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202103192RA (en) | Il-12 heterodimeric fc-fusion proteins | |
| IL281059A (en) | Methods of making chimeric antigen receptor-expressing cells | |
| PH12018501882A1 (en) | Binding proteins and methods of use thereof | |
| MA46113A (fr) | Anticorps dirigés contre l'immunoglobuline de lymphocyte t et la protéine 3 de mucine (tim-3) | |
| IL261200A (en) | Antibodies specific to human poliovirus receptor (pvr) | |
| EP3802581A4 (en) | MULTISPECIFIC BINDING PROTEINS AND IMPROVEMENTS THERETO | |
| IL263894A (en) | Heterodimeric antibodies that bind somatostatin receptor 2 | |
| EP3470430A4 (en) | ANTIBODIES FOR BINDING TO THE INTERLEUKIN-4 RECEPTOR | |
| EP3645998A4 (en) | DEVICE FOR SAMPLE FILTRATION | |
| MA53094A (fr) | Protéine de liaison à l'antigène anti-steap1 | |
| MA41414A (fr) | Protéines de liaison agonistes d' icos | |
| EP3528707A4 (en) | SYSTEMS AND METHOD FOR IMAGING | |
| IL281449A (en) | Anti-ifnar1 antibodies for the treatment of autoimmune diseases | |
| WO2013188448A8 (en) | Dual receptor antagonistic antigen-binding proteins and uses thereof | |
| EP3873807A4 (en) | AIRPLANE BENCH SEAT ARRANGEMENT | |
| EP3538865A4 (en) | DEVICE FOR SAMPLING PREPARATION | |
| EP3647112A4 (en) | CONTROL DEVICE AND LIGHTING SYSTEM | |
| EP3746421A4 (en) | MUSCARINIAN ACETYLCHOLINE RECEPTOR ANTAGONISTS M4 | |
| EP3713636A4 (en) | MONOLITHIC NEURAL INTERFACE SYSTEM | |
| IL270772A (en) | Antibody-cytokine engrafted proteins and methods of use for immune related disorders | |
| PH12019501605A1 (en) | Glucagon receptor binding proteins and methods of use thereof | |
| SG11202007702UA (en) | Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseases | |
| EP3517049A4 (en) | DEVICE FOR TAKING BIOLOGICAL SAMPLES | |
| EP3518662C0 (fr) | Système pour le confort thermique des animaux dans une enceinte d'élevage | |
| EP3438673A4 (en) | AUTOMATIC ANALYSIS DEVICE |